The contribution of single-gene defects to congenital cardiac left-sided lesions in the prenatal setting.
Few data is available for the contribution of single-gene defects to congenital heart defects including left-sided lesions (LSLs) in the fetal population, a segment of the human population not well studied. The aim of this study was to explore the contribution of single-gene defects, and to evaluate the incremental diagnostic yield of whole-exome sequencing (WES) for single-gene defects in fetal LSLs without aneuploidy or a pathogenic copy number variant (pCNV). Between April 10, 2015, and October 30, 2018, we recruited 80 fetuses with a LSL leading to termination of pregnancy. Copy number variation sequencing (CNV-Seq) and WES were performed sequentially on specimens from these fetuses and their parents. CNV-seq was used to identify aneuploidies and pCNVs. WES was used to identify diagnostic genetic variants in cases without aneuploidies or pCNVs. Overall, 27 (33.8%) cases had a genetic diagnosis. CNV-seq analyses identified 6 (7.5%) aneuploidies and 8 (10.0%) pCNVs. WES analyses of the remaining 66 cases revealed diagnostic genetic variants in 13 (19.7%) cases, indicating an incremental yield of 16.3% for the entire cohort. KMT2D was the most frequently mutated gene (7/66, 10.6%), followed by NOTCH1 (4/66, 6.1%). HLHS was most prevalent (4/7) in cases with KMT2D mutation in this cohort. 6 (9.1%) cases were found to have potentially deleterious variants in candidate genes. Single-gene defects contribute a substantial fraction to the etiology of fetal LSLs. KMT2D mutations accounted for approximately 10% of LSLs in the fetal setting. WES has the potential to provide genetic diagnoses in fetal LSLs without aneuploidies or pCNVs. This article is protected by copyright. All rights reserved.